Comprehensive efficacy of omalizumab for severe refractory asthma: A time-series observational study

Annals of Allergy, Asthma and Immunology

Volumn 113, Issue 4, 2014, Pages 470-475.e2

  Tajiri, Tomoko ^a   Niimi, Akio ^a,b   Matsumoto, Hisako ^a   Ito, Isao ^a   Oguma, Tsuyoshi ^a   Otsuka, Kojiro ^a   Takeda, Tomoshi ^a   Nakaji, Hitoshi ^a   Inoue, Hideki ^a   Iwata, Toshiyuki ^a   Nagasaki, Tadao ^a   Kanemitsu, Yoshihiro ^a   Izuhara, Yumi ^a   Mishima, Michiaki ^a  

^a KYOTO UNIVERSITY   (Japan)

^b NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIALLERGIC AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; FLUTICASONE PROPIONATE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; METHACHOLINE; NITRIC OXIDE; OMALIZUMAB; THEOPHYLLINE; ANTI-IGE ANTIBODIES; ANTIASTHMATIC AGENT; ANTIIDIOTYPIC ANTIBODY; IMMUNOGLOBULIN E; METHACHOLINE CHLORIDE; MONOCLONAL ANTIBODY;

ADULT; AIRWAY REMODELING; ARTICLE; ASTHMA; ASTHMA QUALITY OF LIFE QUESTIONNAIRE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG EFFICACY; EOSINOPHIL COUNT; FEMALE; HUMAN; LUNG FUNCTION TEST; MALE; MIDDLE AGED; OBSERVATIONAL STUDY; PEAK EXPIRATORY FLOW; PROSPECTIVE STUDY; REFRACTORY ASTHMA; SCORING SYSTEM; SMALL AIRWAY DISEASE; SPUTUM ANALYSIS; THICKNESS; TIME SERIES ANALYSIS; TREATMENT RESPONSE; BLOOD; CHEMISTRY; DIAGNOSTIC USE; DRUG EFFECTS; IMMUNOLOGY; QUALITY OF LIFE; QUESTIONNAIRE; SPUTUM; TREATMENT OUTCOME;

ADULT; ANTI-ASTHMATIC AGENTS; ANTIBODIES, ANTI-IDIOTYPIC; ANTIBODIES, MONOCLONAL; ANTIBODIES, MONOCLONAL, HUMANIZED; ASTHMA; FEMALE; HUMANS; IMMUNOGLOBULIN E; MALE; METHACHOLINE CHLORIDE; MIDDLE AGED; NITRIC OXIDE; PEAK EXPIRATORY FLOW RATE; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES; RESPIRATORY FUNCTION TESTS; SPUTUM; TREATMENT OUTCOME;

EID: 84908485601     PISSN: 10811206     EISSN: 15344436     Source Type: Journal    
DOI: 10.1016/j.anai.2014.06.004     Document Type: Article

References (51)

1. J. Sunyer, J.M. Anto, and J. Sabria Relationship between serum IgE and airway responsiveness in adults with asthma J Allergy Clin Immunol 95 1995 699 706
2. M. Naqvi, S. Choudhry, and H.J. Tsai Association between IgE levels and asthma severity among African American, Mexican, and Puerto Rican patients with asthma J Allergy Clin Immunol 120 2007 137 143
3. W. Busse, J. Corren, and B.Q. Lanier Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma J Allergy Clin Immunol 108 2001 184 190
4. S.T. Holgate, A.G. Chuchalin, and J. Hebert Efficacy and safety of a recombinant anti-immunoglobulin E antibody (omalizumab) in severe allergic asthma Clin Exp Allergy 34 2004 632 638
5. M. Humbert, R. Beasley, and J. Ayres Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE Allergy 60 2005 309 316
6. R. Djukanovic, S.J. Wilson, and M. Kraft Effects of treatment with anti-immunoglobulin E antibody omalizumab on airway inflammation in allergic asthma Am J Respir Crit Care Med 170 2004 583 593
7. S.R. Durrani, R.K. Viswanathan, and W.W. Busse What effect does asthma treatment have on airway remodeling? Current perspectives J Allergy Clin Immunol 128 2011 439 448 quiz 449-450
8. A. Niimi, H. Matsumoto, and R. Amitani Airway wall thickness in asthma assessed by computed tomography. Relation to clinical indices Am J Respir Crit Care Med 162 2000 1518 1523
9. A. Niimi, H. Matsumoto, and R. Amitani Effect of short-term treatment with inhaled corticosteroid on airway wall thickening in asthma Am J Med 116 2004 725 731
10. H. Matsumoto, A. Niimi, and M. Takemura Long-term changes in airway-wall thickness on computed tomography in asthmatic patients J Investig Allergol Clin Immunol 21 2011 113 119
11. K.F. Rabe, W.J. Calhoun, N. Smith, and P. Jimenez Can anti-IgE therapy prevent airway remodeling in allergic asthma? Allergy 66 2011 1142 1151
12. A.M. Riccio, R.W. Dal Negro, and C. Micheletto Omalizumab modulates bronchial reticular basement membrane thickness and eosinophil infiltration in severe persistent allergic asthma patients Int J Immunopathol Pharmacol 25 2012 475 484
13. M. Hoshino, and J. Ohtawa Effects of adding omalizumab, an anti-immunoglobulin E antibody, on airway wall thickening in asthma Respiration 83 2012 520 528
14. E.D. Bateman, S.S. Hurd, and P.J. Barnes Global strategy for asthma management and prevention: GINA executive summary Eur Respir J 31 2008 143 178
15. P.W. Jones Interpreting thresholds for a clinically significant change in health status in asthma and COPD Eur Respir J 19 2002 398 404
16. E.F. Juniper, G.H. Guyatt, A. Willan, and L.E. Griffith Determining a minimal important change in a disease-specific quality of life questionnaire J Clin Epidemiol 47 1994 81 87
17. E.F. Juniper, P.M. O'Byrne, G.H. Guyatt, P.J. Ferrie, and D.R. King Development and validation of a questionnaire to measure asthma control Eur Respir J 14 1999 902 907
18. H. Matsumoto, A. Niimi, and M. Jinnai Association of alveolar nitric oxide levels with pulmonary function and its reversibility in stable asthma Respiration 81 2011 311 317
19. M. Yamaguchi, A. Niimi, and T. Ueda Effect of inhaled corticosteroids on small airways in asthma: investigation using impulse oscillometry Pulm Pharmacol Ther 22 2009 326 332
20. Y. Shi, A.S. Aledia, A.V. Tatavoosian, S. Vijayalakshmi, S.P. Galant, and S.C. George Relating small airways to asthma control by using impulse oscillometry in children J Allergy Clin Immunol 129 2012 671 678
21. A. Niimi, H. Matsumoto, M. Takemura, T. Ueda, K. Chin, and M. Mishima Relationship of airway wall thickness to airway sensitivity and airway reactivity in asthma Am J Respir Crit Care Med 168 2003 983 988
22. H. Matsumoto, A. Niimi, and M. Takemura Relationship of airway wall thickening to an imbalance between matrix metalloproteinase-9 and its inhibitor in asthma Thorax 60 2005 277 281
23. T. Ohara, T. Hirai, and S. Sato Longitudinal study of airway dimensions in chronic obstructive pulmonary disease using computed tomography Respirology 13 2008 372 378
24. T. Ueda, A. Niimi, and H. Matsumoto Role of small airways in asthma: investigation using high-resolution computed tomography J Allergy Clin Immunol 118 2006 1019 1025
25. T. Tajiri, H. Matsumoto, and H. Hiraumi Efficacy of omalizumab in eosinophilic chronic rhinosinusitis patients with asthma Ann Allergy Asthma Immunol 110 2013 387 388
26. P.E. Silkoff, F.A. Romero, N. Gupta, R.G. Townley, and H. Milgrom Exhaled nitric oxide in children with asthma receiving Xolair (omalizumab), a monoclonal anti-immunoglobulin E antibody Pediatrics 113 2004 e308 e312
27. M. Contoli, M. Kraft, and Q. Hamid Do small airway abnormalities characterize asthma phenotypes? In search of proof Clin Exp Allergy 42 2012 1150 1160
28. C. Ward, M. Pais, and R. Bish Airway inflammation, basement membrane thickening and bronchial hyperresponsiveness in asthma Thorax 57 2002 309 316
29. A. Chetta, A. Zanini, and A. Foresi Vascular component of airway remodeling in asthma is reduced by high dose of fluticasone Am J Respir Crit Care Med 167 2003 751 757
30. R. Lundgren, M. Soderberg, P. Horstedt, and R. Stenling Morphological studies of bronchial mucosal biopsies from asthmatics before and after ten years of treatment with inhaled steroids Eur Respir J 1 1988 883 889
31. R.H. Brown, and W. Mitzner Effect of lung inflation and airway muscle tone on airway diameter in vivo J Appl Physiol 80 1996 1581 1588
32. J. Bousquet, S. Wenzel, S. Holgate, W. Lumry, P. Freeman, and H. Fox Predicting response to omalizumab, an anti-IgE antibody, in patients with allergic asthma Chest 125 2004 1378 1386
33. E.D. Bateman, S.S. Hurd, and P.J. Barnes Global strategy for asthma management and prevention: GINA executive summary Eur Respir J 31 2008 143 178
34. P.W. Jones, F.H. Quirk, C.M. Baveystock, and P. Littlejohns A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire Am Rev Respir Dis 145 1992 1321 1327
35. E.F. Juniper, A.S. Buist, F.M. Cox, P.J. Ferrie, and D.R. King Validation of a standardized version of the Asthma Quality of Life Questionnaire Chest 115 1999 1265 1270
36. E.F. Juniper, P.M. O'Byrne, G.H. Guyatt, P.J. Ferrie, and D.R. King Development and validation of a questionnaire to measure asthma control Eur Respir J 14 1999 902 907
37. ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005 Am J Respir Crit Care Med 171 2005 912 930
38. P. Condorelli, H.W. Shin, A.S. Aledia, P.E. Silkoff, and S.C. George A simple technique to characterize proximal and peripheral nitric oxide exchange using constant flow exhalations and an axial diffusion model J Appl Physiol 102 2007 417 425
39. H. Matsumoto, A. Niimi, and M. Jinnai Association of alveolar nitric oxide levels with pulmonary function and its reversibility in stable asthma Respiration 81 2011 311 317
40. E. Oostveen, D. MacLeod, and H. Lorino The forced oscillation technique in clinical practice: methodology, recommendations and future developments Eur Respir J 22 2003 1026 1041
41. M. Yamaguchi, A. Niimi, and T. Ueda Effect of inhaled corticosteroids on small airways in asthma: investigation using impulse oscillometry Pulm Pharmacol Ther 22 2009 326 332
42. Y. Shi, A.S. Aledia, A.V. Tatavoosian, S. Vijayalakshmi, S.P. Galant, and S.C. George Relating small airways to asthma control by using impulse oscillometry in children J Allergy Clin Immunol 129 2012 671 678
43. M.R. Miller, J. Hankinson, and V. Brusasco Standardisation of spirometry Eur Respir J 26 2005 319 338
44. T. Takishima, W. Hida, H. Sasaki, S. Suzuki, and T. Sasaki Direct-writing recorder of the dose-response curves of the airway to methacholine. Clinical application Chest 80 1981 600 606
45. A. Niimi, H. Matsumoto, M. Takemura, T. Ueda, K. Chin, and M. Mishima Relationship of airway wall thickness to airway sensitivity and airway reactivity in asthma Am J Respir Crit Care Med 168 2003 983 988
46. H. Matsumoto, A. Niimi, and M. Takemura Relationship of airway wall thickening to an imbalance between matrix metalloproteinase-9 and its inhibitor in asthma Thorax 60 2005 277 281
47. H. Matsuoka, A. Niimi, and H. Matsumoto Specific IgE response to Trichophyton and asthma severity Chest 135 2009 898 903
48. T. Ohara, T. Hirai, and S. Sato Longitudinal study of airway dimensions in chronic obstructive pulmonary disease using computed tomography Respirology 13 2008 372 378
49. N. Sakai, M. Mishima, K. Nishimura, H. Itoh, and K. Kuno An automated method to assess the distribution of low attenuation areas on chest CT scans in chronic pulmonary emphysema patients Chest 106 1994 1319 1325
50. M. Mishima, T. Hirai, and H. Itoh Complexity of terminal airspace geometry assessed by lung computed tomography in normal subjects and patients with chronic obstructive pulmonary disease Proc Natl Acad Sci U S A 96 1999 8829 8834
51. T. Ueda, A. Niimi, and H. Matsumoto Role of small airways in asthma: investigation using high-resolution computed tomography J Allergy Clin Immunol 118 2006 1019 1025